Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Lung Cancer

Trial CONCORDE
Cancer Type Lung Cancer
Hospital(s) Belfast City Hospital
Information

A platform study of DNA damage response inhibitors in combination with conventional radiotherapy in non small cell lung cancer

Click Here to view Cancer Research UK trial summary
Trial PACIFIC-9
Cancer Type Lung Cancer
Hospital(s) Belfast City Hospital
Information

A Phase III, double-blind, placebo-controlled, Randomized, Multicentre, International Study of Durvalumab Plus Oleclumab and Durvalumab Plus Monalizumab in Patients with Locally Advanced (Stage III), Unresectable, Non-small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Definitive, Platinum-Based Concurrent Chemoradiation Therapy

Click Here to view Cancer Research UK trial summary